| Symbol | HAE |
|---|---|
| Name | HAEMONETICS CORP |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Surgical & Medical Instruments & Apparatus |
| Address | 125 SUMMER STREET, BOSTON, MA 02110 |
| Telephone | 7818487100 |
| Fax | — |
| — | |
| Website | https://www.haemonetics.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0000313143 |
| Description | Haemonetics Corp sells products used to process, handle, and analyze blood. The firm sells products in three categories: Plasma, Blood Center and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, and anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood. Hospital, which is comprised of Hemostasis Management, Cell Salvage, Transfusion Management and Vascular Closure products, includes devices and methodologies for measuring coagulation characteristics of blood, surgical blood salvage systems, specialized blood cell processing systems and disposables, blood transfusion management software and vascular closure devices. Additional info from NASDAQ: |
New Form SCHEDULE 13G/A - HAEMONETICS CORP <b>Filed:</b> 2026-05-13 <b>AccNo:</b> 0001213900-26-055541 <b>Size:</b> 18 KB
Read moreDArecca James 🔴 sold 655 shares of HAEMONETICS CORP (HAE) at $59.26 Transaction Date: May 01, 2026 | Filing ID: 000026
Read moreNew Form SCHEDULE 13G - HAEMONETICS CORP <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0002100119-26-000608 <b>Size:</b> 7 KB
Read moreNew Form SCHEDULE 13G - HAEMONETICS CORP <b>Filed:</b> 2026-04-29 <b>AccNo:</b> 0002100121-26-000346 <b>Size:</b> 7 KB
Read moreHaemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026
Read moreNew Form SCHEDULE 13G/A - HAEMONETICS CORP <b>Filed:</b> 2026-03-27 <b>AccNo:</b> 0000102909-26-001482 <b>Size:</b> 7 KB
Read moreNew Form SCHEDULE 13G - HAEMONETICS CORP <b>Filed:</b> 2026-03-03 <b>AccNo:</b> 0001213900-26-023263 <b>Size:</b> 45 KB
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT07366671 | SAvvywire for Pacing and Procedural Hemodynamics In Transcatheter Aortic Valve … | — | TAVI(Transcatheter Aortic Valve Implantation) | Recruiting | 2026-01-12 | 2028-03-01 | ClinicalTrials.gov |
| NCT07414121 | VASC-AF Study: Vascular Closure vs Manual Compression | Na | Atrial Fibrillation | Recruiting | 2025-04-22 | 2026-12-01 | ClinicalTrials.gov |
| NCT05517811 | Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma … | — | Liver Cancer | Recruiting | 2022-06-26 | 2028-07-31 | ClinicalTrials.gov |
| NCT06352125 | An Observational Trial to Assess the Performance of the TEG® 6s Diagnostic Syst… | — | Surgery | Completed | 2021-12-09 | 2023-01-31 | ClinicalTrials.gov |
| NCT06261580 | Normal Reference Range Study With the TEG6s Heparin Neutralization Cartridge in… | — | Healthy | Completed | 2021-07-28 | 2021-10-25 | ClinicalTrials.gov |
| NCT04493307 | The Evaluation of Hemostasis in Hospitalized COVID-19 Patients | — | COVID-19 | Unknown | 2020-06-30 | 2021-06-01 | ClinicalTrials.gov |
| NCT04320823 | IMPACT (Improving Plasma Collection) Clinical Trial | Na | Apheresis Related Hypotension | Completed | 2020-01-06 | 2020-04-27 | ClinicalTrials.gov |
| NCT02798328 | Direct Oral Anticoagulant Assay Detection & Classification Study for the TEG 6S… | — | DOAC Eligible Subjects | Completed | 2016-08-01 | 2017-09-01 | ClinicalTrials.gov |
| NCT02476851 | Clinical Investigation to Evaluate the Haemonetics POLFA Modified Sample Needle… | Na | Transmission, Blood, Recipient/Donor | Completed | 2015-06-01 | 2015-09-01 | ClinicalTrials.gov |
| NCT02110576 | Procedure For The Reference Range Study For Absolute MA | — | Transmission, Blood, Recipient/Donor | Completed | 2014-05-01 | 2015-03-01 | ClinicalTrials.gov |
| NCT02145507 | Evaluation of Whole Blood With CPD Anticoagulant and AS-7/SOLX Additive Solution | Phase1 | Blood Donors | Completed | 2014-04-01 | 2015-01-01 | ClinicalTrials.gov |
| NCT01764061 | Clinical Investigational Protocol for 2 RBC Single Unit Recovery on MCS®+ 8150 … | — | Red Blood Cell Donation | Completed | 2013-01-01 | 2013-09-01 | ClinicalTrials.gov |
| NCT01756976 | Clinical Evaluation of the OrthoPAT Advance System | — | Transmission, Blood, Recipient/Donor | Completed | 2012-12-01 | 2013-08-01 | ClinicalTrials.gov |
| NCT01779401 | Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombot… | Na | Coronary Heart Disease | Completed | 2012-09-01 | 2016-09-01 | ClinicalTrials.gov |
| NCT01809054 | Pilot Study Evaluating Alterations in Thrombogenicity and Platelet Reactivity F… | Phase4 | Primary Total Hip and Knee Arthroplasty | Completed | 2012-04-01 | 2013-02-01 | ClinicalTrials.gov |
| NCT01428102 | RapidTEG MA Validation | — | Coagulation | Terminated | 2011-07-01 | 2012-10-01 | ClinicalTrials.gov |
| NCT01359878 | Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Rando… | Phase2 | Postpartum Haemorrhage | Completed | 2011-05-01 | 2013-07-01 | ClinicalTrials.gov |
| NCT01357928 | Thromboelastography (TEG) Reference Range Study | — | Coagulation | Completed | 2011-04-01 | 2011-10-01 | ClinicalTrials.gov |
| NCT01228058 | A Prospective Evaluation of Thromboelastography for Identifying Coagulopathy in… | — | Coagulopathy | Completed | 2010-11-01 | 2012-01-01 | ClinicalTrials.gov |
| NCT01536496 | Comparison of Rapid Thrombelastography and Conventional Coagulation Testing for… | Na | Acute Coagulopathy | Completed | 2010-09-01 | 2014-07-01 | ClinicalTrials.gov |
| NCT01023360 | Evaluation of Antiplatelet Drug Resistance in Taiwanese With VASP & Platelet Ma… | Phase4 | 30 Healthy People | Unknown | 2008-05-01 | 2010-10-01 | ClinicalTrials.gov |
| NCT00998088 | Blood Management in Orthopedic Surgery | Phase4 | Osteoarthritis | Completed | 2004-05-01 | 2009-09-01 | ClinicalTrials.gov |